S. 1907 (119th)Bill Overview

Plant Biostimulant Act of 2025

Environmental Protection|Environmental Protection
Cosponsors
Support
Bipartisan
Introduced
May 22, 2025
Discussions
Bill Text
Current stageCommittee

Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

This bill amends the Federal Insecticide, Fungicide, and Rodenticide Act to add statutory definitions for "plant biostimulant," "plant regulator," "nutritional chemical," and "vitamin hormone product," and to exclude certain biostimulants from the plant regulator definition. It requires the EPA Administrator to revise related regulations within 120 days of enactment.

Why people may split

Progressives emphasize environmental safeguards and oversight concerns.

Watch point

Relative to its intended legislative type, this bill establishes clear statutory definitions for plant biostimulants and related terms, integrates those changes into existing law, and imposes short regulatory and study deadlines, but it omits appropriations, detailed implementation procedures, and enforcement or dispute-resolution mechanisms.

This bill amends the Federal Insecticide, Fungicide, and Rodenticide Act to add statutory definitions for "plant biostimulant," "plant regulator," "nutritional chemical," and "vitamin hormone product," and to exclude certain biostimulants from the plant regulator definition.

It requires the EPA Administrator to revise related regulations within 120 days of enactment.

The bill also directs the USDA Secretary to conduct a study on plant biostimulant types and practices that improve soil health, nutrient management, runoff reduction, carbon sequestration, and related outcomes, with a public report due within two years after funding is available.

Passage45/100

Content is narrow and technical (increases viability) but many standalone bills die in committee or face scheduling/logistics issues.

CredibilityPartially aligned

Relative to its intended legislative type, this bill establishes clear statutory definitions for plant biostimulants and related terms, integrates those changes into existing law, and imposes short regulatory and study deadlines, but it omits appropriations, detailed implementation procedures, and enforcement or dispute-resolution mechanisms.

Contention32/100

Progressives emphasize environmental safeguards and oversight concerns.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
ManufacturersFederal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • ManufacturersProvides regulatory clarity that may reduce registration and compliance costs for biostimulant manufacturers.
  • Potential benefitCould spur industry innovation and market growth, potentially creating related private-sector jobs.
  • Potential benefitEncourages adoption of products that may improve nutrient efficiency and reduce fertilizer runoff on farms.
Likely burdened
  • Federal agenciesMay reduce federal oversight, allowing some products to avoid pesticide registration and safety review.
  • Potential burdenThe "structurally similar" synthetic exclusion could create a regulatory loophole for novel compounds.
  • Potential burdenShort 120-day EPA deadline risks rushed regulatory revisions with limited stakeholder input.
03 · Why people split

Why the argument around this bill splits.

Progressives emphasize environmental safeguards and oversight concerns.
Progressive60%

Generally supportive of research and soil-health goals, but cautious about removing regulatory coverage for products.

Concerned that statutory exclusions could weaken environmental and safety review without clear safeguards.

Views USDA study positively but will want transparency and strong science.

Split reaction
Centrist75%

Sees the bill as a pragmatic clarification to reduce regulatory ambiguity and spur beneficial research.

Appreciates defined terms and a government study, while wanting clear implementation, realistic timelines, and assurance of scientific rigor.

Concerned about unspecified costs and the 120-day regulatory deadline.

Leans supportive
Conservative85%

Likely favorable because the bill narrows regulatory reach, provides clear definitions, and lowers compliance uncertainty for agricultural innovators.

Views the USDA study as modest and useful, though some prefer less federal study spending.

Overall sees the bill as pro-innovation and deregulatory.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood45/100

Content is narrow and technical (increases viability) but many standalone bills die in committee or face scheduling/logistics issues.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Whether funds will be provided for the USDA study
  • Stakeholder reactions (industry vs environmental groups)
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Progressives emphasize environmental safeguards and oversight concerns.

Content is narrow and technical (increases viability) but many standalone bills die in committee or face scheduling/logistics issues.

Unlocked analysis

Relative to its intended legislative type, this bill establishes clear statutory definitions for plant biostimulants and related terms, integrates those changes into existing law, and imposes short regulatory and study…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis